Healthcare / Medical - Equipment & ServicesUpdated 2026-05-10 22:07 UTC

LON/0J6Z stock hub

LON/0J6Z has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

LON/0J6Zis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

24.2B

London Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

LON/0J6Z

In the news

Latest news · LON/0J6Z

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E25.5

P25 12.9P50 16.9P75 23.5

Trailing P/E28.3

P25 15.9P50 22.9P75 35.8

ROE6.3

P25 -54.2P50 2.1P75 13.7

ROIC8

P25 -38.1P50 3.3P75 11.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All LON/0J6Z market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

216

Groups with data

Currency

USD

Showing 216 of 216 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	UK
Employees	67,060
Employees Change	-1,920%
Employees Change Percent	-2.84
Enterprise value	$31.2B
Exchange	London Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Medical - Equipment & Services
Isin	US4448591028
Last refreshed	2026-05-10
Market cap	$24.2B
Price	$260
Price currency	USD
Rev Per Employee	1,549,392.28x
Sector	Healthcare
Sic	6324
Symbol	lon/0J6Z
Website	https://www.humana.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	3.53%
EV Earnings	36.45x
EV/EBIT	14.07x
EV/EBITDA	12.21x
EV/FCF	32.38x
EV/Sales	0.31x
FCF yield	3.98%
Forward P/E	25.52x
P/B ratio	1.72x
P/E ratio	28.31x
P/S ratio	0.23x
PE Ratio10 Y	21.19x
PE Ratio3 Y	22.15x
PE Ratio5 Y	21.47x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	2.26%
EBITDA Margin	2.45%
FCF margin	0.93%
Gross margin	14.01%
Gross Profit	$14.6B
Net Income	$855.8M
Net Income Growth	-33.92%
Net Income Growth Q	-4.66%
Net Income Growth Years	0%
Net Income Growth3 Y	-28.68%
Net Income Growth5 Y	-21.21%
Pretax Margin	1.01%
Profit Margin	0.82%
Profit Per Employee	$12,761
Profitable Years	14
ROA	3.64
Roa5y	5.16
ROCE	9.16
ROE	6.28
Roe5y	13.52
ROIC	8
Roic5y	10.28

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	4.58%
Cagr3y	-20.29%
Cagr5y	-10.08%
Div CAGR3	-1.3%
Div CAGR5	5.98%
EPS Growth	-33.91
EPS Growth Q	-4.56
EPS Growth Years	0
EPS Growth3 Y	-27.55
EPS Growth5 Y	-19.77
FCF Growth	-46.58%
FCF Growth Q	380.09%
FCF Growth3 Y	-49.55%
FCF Growth5 Y	-17.19%
OCF Growth	-35.84%
OCF Growth Q	278.85%
OCF Growth10 Y	3.86%
OCF Growth3 Y	-44.81%
OCF Growth5 Y	-15.69%
Revenue Growth	14.08x
Revenue Growth Q	23.47x
Revenue Growth Quarters	34x
Revenue Growth Years	8x
Revenue Growth3 Y	12.78x
Revenue Growth5 Y	11.7x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$2.58
Assets	$41.9B
Cash	$16.6B
Debt	$10.9B
Debt EBITDA	$4.04
Debt Equity	$0.77
Debt FCF	$11.3
Equity	$14.1B
Interest Coverage	4.66
Liabilities	$27.7B
Net Cash	$-7.1B
Net Cash By Market Cap	$-29.45
Net Debt EBITDA	$2.8
Net Debt Equity	$0.51
Net Debt FCF	$7.41
Tangible Book Value	$5.2B
Tangible Book Value Per Share	$43.54
WACC	5.81

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.77
Net Working Capital	$10.3B
Quick ratio	1.26
Working Capital	$12.6B

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.01%
Dividend Growth	-4.49%
Dividend Growth Years	0%
Dividend per share	$2.63
Dividend Years	10
Dividend Yield	1.01%
Ex Div Date	2026-03-27
Last Dividend	$0.67
Payout Frequency	Quarterly
Payout Ratio	37.08%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	4.58%
200-day SMA	241.3
3Y total return	-49.37%
50-day SMA	196
50-day SMA vs 200-day SMA	50under200
5Y total return	-41.21%
All Time High	569.9
All Time High Change	-54.34%
All Time High Date	2022-11-03
All Time Low	162
All Time Low Change	60.62%
All Time Low Date	2026-03-20
ATR	12.52
Beta	0.68
Ch YTD	0.59
High	260.2
High52	315.1
High52 Date	2025-09-05
High52ch	-17.42%
Low	240
Low52	162
Low52 Date	2026-03-20
Low52ch	60.62%
Ma50ch	32.75%
Price vs 200-day SMA	7.83%
RSI	84.62
RSI Monthly	47.74
RSI Weekly	61.15
Sharpe ratio	0.23x
Sortino ratio	0.44
Total Return	1%
Tr YTD	1.11
Tr1m	31.32%
Tr1w	9.68%
Tr3m	34.06%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	$2.3B
Operating margin	2.26

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	119,752,401%
Net Borrowing	470,182,474
Shares Insiders	0.13%
Shares Institutions	104.02%
Shares Qo Q	0.26%
Shares Yo Y	0.01%
Short Ratio	2.81

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$779.3M
Average Volume	1,055.55x
Bv Per Share	117.2
CAPEX	$-433.2M
Ch1m	31.32
Ch1w	9.68
Ch1y	2.95
Ch3m	33.38
Ch3y	-51.16
Ch5y	-44.04
Ch6m	4.24
Change	5.51%
Change From Open	8.42
Close	246.6
Days Gap	-2.68
Dollar Volume	129,842
Earnings Date	2026-04-29
EBIT	$2.3B
EBITDA	$2.5B
EPS	$7.09
F Score	6
FCF	$963.3M
FCF EV Yield	3.09x
Financing CF	-415,760,445
Fiscal Year End	December
Founded	1,961
Goodwill	7,693,828,346
Graham Number	177.09676
Graham Upside	-31.94
Income Tax	$181M
Investing CF	-449,839,170
Is Primary Listing	0
Last Earnings Date	2026-04-29
Last Report Date	2026-03-31
Lynch Fair Value	$45.96
Lynch Upside	-82.34
Ma150	231.3
Ma150ch	12.51%
Ma20	223.5
Ma20ch	16.44%
Net CF	530,870,805
Next Earnings Date	2026-07-29
Open	240
P FCF Ratio	25.15
P OCF Ratio	17.35
Payment Date	2026-04-24
Position In Range	100
Ppne	1,591,725,380
Price Date	2026-05-08
Price EBITDA	$9.52
Ptbv Ratio	4.63
Relative Volume	0.49x
Revenue	103,902,246,000x
SBC By Revenue	0.18x
Share Based Comp	184,025,115
Tax By Revenue	0.17x
Tax Rate	17.27%
Tr6m	5.14%
Volume	499

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

LON/0J6Z dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+1.0%

$2.63 annual per share

Payout ratio

+37.1%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+6.0%

0 consecutive years of growth

Total shareholder yield

+1.0%

Next ex-dividend date: 2026-03-27

Performance

LON/0J6Z stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns LON/0J6Z?

Insider, institutional, and short-interest positioning.

Institutional ownership

+104.0%

Share of float held by funds and institutions

Insider ownership

+0.1%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

LON/0J6Z momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

84.6

Above 70: short-term overbought

Price vs 200-day MA

+7.8%

50/200-day relationship not available

Beta (5Y)

0.68

Less volatile than the market

Sharpe ratio

0.23

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About LON/0J6Z

Hub-level FAQ points readers to the deeper analysis pages.

What is the current lon/0J6Z stock rating?

lon/0J6Z is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full lon/0J6Z analysis?

The full report lives at /stocks/lon/0J6Z/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for lon/0J6Z?

The latest report frames lon/0J6Z around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the lon/0J6Z page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.